Clindamycin phosphate NDC 43066-993

NDC codes

FDA NDC Directory

Product NDC (as listed)43066-993Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43066-0993Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
43066-993-24	43066099324	24 BAG in 1 CASE (43066-993-24) / 50 mL in 1 BAGMarketed from Feb 28, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clindamycin phosphate
Generic name (nonproprietary): clindamycin phosphate
Active ingredients: Clindamycin phosphate — 600 mg/50mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Baxter Healthcare Corporation
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208084
Marketing start: Jun 28, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers: Product ID 43066-993_b31a3e6c-9d61-4038-be8b-6e2ca0f6ca0bSPL ID b31a3e6c-9d61-4038-be8b-6e2ca0f6ca0bSPL set ID 1a42c3b2-90b5-4a78-9f18-fa789742b033RxCUI 309335, 309336UNII EH6D7113I8
Pharmacologic class: Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N443066099324 followed by a unit qualifier and the quantity

Package 43066-0993-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 15, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Clindamycin Injection USP in 5% Dextrose products are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin Injection USP in 5% Dextrose products are also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of antibacterial drug-associated pseudomembranous colitis, as described in the BOXED WARNING , before selecting clindamycin the physician should consider the nature of the infe…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 208084

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208084
Product	Strength	Form · route	Labeler	Product NDC
Clindamycin phosphate	Clindamycin phosphate 600 mg/50mL	Injection, SolutionIntravenous	Baxter Healthcare Company	0338-3612
Clindamycin phosphate	Clindamycin phosphate 600 mg/50mL	Injection, SolutionIntravenous	Baxter Healthcare Company	0338-3616
Clindamycin phosphate	Clindamycin phosphate 900 mg/50mL	Injection, SolutionIntravenous	Baxter Healthcare Company	0338-3814
Clindamycin phosphate	Clindamycin phosphate 900 mg/50mL	Injection, SolutionIntravenous	Baxter Healthcare Company	0338-4114
Clindamycin phosphate	Clindamycin phosphate 900 mg/50mL	Injection, SolutionIntravenous	Baxter Healthcare Corporation	43066-995
Clindamycin phosphate	Clindamycin phosphate 300 mg/50mL	Injection, SolutionIntravenous	Baxter Healthcare Company	0338-3410